P

Inventor

LANMAN BRIAN ALAN

US30 patents
⚠️ This page may combine multiple inventors who share the name “LANMAN BRIAN ALAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

AMGEN INC

28 patents
US10640504B2May 5, 2020

Inhibitors of KRAS G12C and methods of using the same

AMGEN INC50 citations97
US10532042B2Jan 14, 2020

KRAS G12C inhibitors and methods of using the same

AMGEN INC49 citations97
US10519146B2Dec 31, 2019

KRAS G12C inhibitors and methods of using the same

AMGEN INC81 citations97
US11306087B2Apr 19, 2022

Inhibitors of KRAS G12C and methods of using the same

AMGEN INC16 citations94
US11096939B2Aug 24, 2021

KRAS G12C inhibitors and methods of using the same

AMGEN INC24 citations94
US11090304B2Aug 17, 2021

KRAS G12C inhibitors and methods of using the same

AMGEN INC33 citations94
US11045484B2Jun 29, 2021

KRAS G12C inhibitors and methods of using the same

AMGEN INC24 citations94
US11285135B2Mar 29, 2022

KRAS G12C inhibitors and methods of using the same

AMGEN INC20 citations93
US10988485B2Apr 27, 2021

KRAS G12C inhibitors and methods of using the same

AMGEN INC27 citations92
US11053226B2Jul 6, 2021

KRAS G12C inhibitors and methods of using the same

AMGEN INC25 citations91
US12083121B2Sep 10, 2024

Substituted piperazines as KRAS G12C inhibitors

AMGEN INC7 citations85
US11993597B2May 28, 2024

Inhibitors of KRAS G12C and methods of using the same

AMGEN INC8 citations85
US11905281B2Feb 20, 2024

KRAS G12C inhibitors and methods of using the same

AMGEN INC13 citations85
US11766436B2Sep 26, 2023

KRAS G12C inhibitors and methods of using the same

AMGEN INC11 citations85
US11285156B2Mar 29, 2022

Substituted piperazines as KRAS G12C inhibitors

AMGEN INC16 citations85
US10632128B2Apr 28, 2020

Compounds that inhibit Mcl-1 protein

AMGEN INC5 citations83
US8772480B2Jul 8, 2014

Inhibitors of PI3 kinase and/or mTOR

AMGEN INC5 citations71
US12440491B2Oct 14, 2025

KRAS G12C inhibitors and methods of using the same

AMGEN INC1 citations64
US12583854B2Mar 24, 2026

KRAS G12C inhibitors and methods of using the same

AMGEN INC0 citations62
US11807693B2Nov 7, 2023

Apelin polypeptides

AMGEN INC0 citations62
US7842685B2Nov 30, 2010

S1P1 receptor agonists and use thereof

AMGEN INC3 citations62
US11224601B1Jan 18, 2022

Compounds that inhibits MCL-1 protein

AMGEN INC0 citations61
US10941182B2Mar 9, 2021

Apelin polypeptides

AMGEN INC0 citations61
US11845760B2Dec 19, 2023

PRMT5 inhibitors

AMGEN INC1 citations56
US11364248B2Jun 21, 2022

Compounds that inhibit Mcl-1 protein

AMGEN INC0 citations52
US11279712B2Mar 22, 2022

Macrocyclic compounds that inhibit MCL-1 protein

AMGEN INC0 citations51
US10821115B2Nov 3, 2020

Compounds that inhibit Mcl-1 protein

AMGEN INC0 citations51
US12570672B2Mar 10, 2026

Macrocyclic compounds and methods of use

AMGEN INC0 citations41

EPIX PHARM INC

1 patent

WANG HUI-LING

1 patent